The Future of Clinical Trials in Colombia

Clinical Trials in: Mexico, Argentina, Colombia and Brazil.

Locally-Based, Full Service CRO

Contact us today to learn more.

+ 0
Sites Throughout LATAM
+ 200
Patients in our network
+ 0
Conducted Studies
0 %
Lost-to-Follow Up rate
As a leading CRO in LATAM, we specialize in supporting clinical trials throughout the region. Our extensive experience and broad network of clinical sites enable us to execute trials with speed and efficiency, ensuring high patient recruitment and retention rates.

The Future of Clinical Trials in Colombia

The Future of Clinical Trials in Colombia – Biotech Clinical Trials

Clinical trials are the backbone of medical research, driving innovation and improving patient care. In recent years, Colombia has emerged as a promising destination for conducting clinical trials. With a robust healthcare system, a large and diverse population, and favorable regulatory reforms, Colombia is poised to shape the future of clinical trials.

This blog explores the current landscape of clinical trials in Colombia, highlighting the advancements, opportunities, and challenges that lie ahead.

Regulatory Reforms and Favorable Environment

Colombia has implemented regulatory reforms to streamline the clinical trial approval process and align with international standards. The National Institute of Food and Drug Surveillance (INVIMA) oversees clinical trial regulations, ensuring participant safety and data integrity.

These reforms have expedited approval timelines and fostered a favorable environment for conducting trials. Colombia’s commitment to upholding ethical standards and providing regulatory clarity attracts both domestic and international sponsors.

Expansion into Diverse Therapeutic Areas

Clinical trials in Colombia have diversified beyond traditional areas, such as infectious diseases, to encompass a wide range of specialties. With a growing focus on oncology, cardiology, neurology, and other therapeutic fields, Colombia offers a unique opportunity for researchers to explore new treatment options and therapies.

This expansion benefits both local patients, who gain access to cutting-edge treatments, and the global scientific community, which gains insights into disease patterns and treatment responses.

Collaboration and International Partnerships

Collaborations between Colombian research institutions, pharmaceutical companies, and international organizations have played a significant role in advancing clinical trials. These partnerships foster knowledge exchange, capacity building, and resource-sharing, enhancing the quality and impact of clinical research.

Collaborative efforts enable the introduction of innovative trial methodologies, promote interdisciplinary approaches, and contribute to scientific excellence.

Access to Diverse Patient Populations

Colombia’s population represents a diverse mix of ethnicities and genetic backgrounds, offering a valuable resource for clinical trials. This diversity allows for more accurate representation of patients from different racial and ethnic groups, improving the generalizability of study results.

It also facilitates the understanding of variations in treatment responses and potential genetic factors influencing diseases. The inclusion of diverse populations in clinical trials is essential for addressing health disparities and ensuring equitable healthcare delivery.

The Future of Clinical Trials in Colombia

The Future of Clinical Trials in Colombia

The Future of Clinical Trials in Colombia

Technological Advancements and Data Management

The future of clinical trials in Colombia is intertwined with technological advancements and data management innovations. The adoption of electronic data capture systems, telemedicine, wearable devices, and remote monitoring has the potential to revolutionize the conduct and efficiency of clinical trials.

These technologies enhance patient engagement, enable real-time data analysis, and facilitate remote participation, reducing barriers and improving overall trial outcomes. Colombia’s growing technological infrastructure and increasing digital literacy create a favorable environment for the integration of these advancements.

Patient-Centric Approaches and Real-World Evidence

The future of clinical trials in Colombia will emphasize patient-centric approaches and the integration of real-world evidence. Patient engagement, patient-reported outcomes, and shared decision-making will be prioritized to ensure that trial design and outcomes align with patients’ preferences and needs.

Additionally, the use of real-world data collected from routine clinical practice will complement traditional clinical trial data, providing a more comprehensive understanding of treatment effectiveness, safety, and long-term outcomes.

Strengthening Regulatory Oversight and Quality Assurance

To ensure the continued growth and success of clinical trials in Colombia, robust regulatory oversight and quality assurance measures are crucial. Regular inspections, audits, and adherence to Good Clinical Practice (GCP) guidelines will uphold the highest standards of participant safety, data integrity, and ethical conduct.

Collaboration between regulatory authorities, sponsors, and research institutions will facilitate ongoing monitoring and evaluation, promoting transparency, and fostering a culture of continuous improvement.

Furthermore, investments in training programs and professional development opportunities for investigators and research staff will enhance their knowledge and skills, contributing to the overall quality of clinical trials.

Public Awareness and Community Engagement

Increasing public awareness and community engagement are vital for the future of clinical trials in Colombia. Educating the public about the importance of clinical research, its benefits, and the rights of participants will help overcome misconceptions and build trust.

Collaborative efforts between research institutions, healthcare providers, and patient advocacy groups can help disseminate accurate information, address concerns, and encourage participation in clinical trials. Engaging with communities to understand their needs and perspectives will ensure that trials are designed with their best interests in mind, ultimately improving healthcare outcomes for the population.


Colombia is well-positioned to shape the future of clinical trials, leveraging its favorable regulatory environment, diverse patient population, collaborative networks, and technological advancements. With ongoing reforms, strengthened regulatory oversight, and a focus on patient-centric approaches, Colombia has the potential to attract more international trials, drive innovation, and contribute significantly to medical research and healthcare advancements.

By addressing challenges, fostering partnerships, and promoting public awareness, Colombia can unlock the full potential of clinical trials, leading to improved patient care, enhanced treatment options, and a brighter future for healthcare in the country.

The Future of Clinical Trials in Colombia

Source: Pro Colombia

Welcome to Cohortias!

of Latin America

Simplify Your Clinical Trials with Our Expert Infrastructure in Latin America

Say goodbye to the complex, costly, and disorganized process of conducting clinical trials. Our infrastructure in Latin America streamlines the launch of studies and ensures adherence to international standards. Schedule a call with us today to discover the path to simplified clinical research in Latin America.

The Future of Clinical Trials in Colombia

Explore What We Are Doing Better

We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research in Latin America.

Early Phase Trials

- First-in-Human Studies.
- Get to patients faster, no IND necessary.
- Valid data for FDA submission.

Rescue Studies

- Regain lost time and boost patient recruitment.
- We work alongside Global CROs to get studies back on track.
- More than 200 sites available.

Phase II & III Trials

- Full-Service Clinical Outsourcing.
- Proven infrastructure that can handle any trial.
- Local Regulatory Experts
- Wide network of sites and physicians.

Medical Devices

- A fast-track platform that will meet your timeline.
- We take care of everything, from shipping requirements all the way to data collection.
The Future of Clinical Trials in Colombia

Full Service CRO in LATAM

Outsourcing Clinical Trials to Latin America

Unlock the advantages and opportunities of outsourcing clinical trials to Latin America. Diverse patient population, streamlined regulations, and cost-effectiveness

Lower Operating Costs

From lower labor costs to lower costs for rent, utilities, and equipment, you can save money on your clinical trial budget while still ensuring the quality of your trial

Access to Emerging Markets

Latin America offers access to emerging markets, providing an opportunity for pharmaceutical companies to expand their reach and reach new patient populations.

The Future of Clinical Trials in Colombia

Cohortias is redefining Clinical Research in Latin America

We are committed to become leaders in providing clinical research services in Latin America. Here at Cohortias, we combine our academic roots, proven experience and a large pool of patients from an extensive network of sites.

Our main purpose is to deliver high quality data.

The Future of Clinical Trials in Colombia

Clinical Research in Latin America

Cohortias has built an extensive and highly reputable network of clinical sites which can access patients in a timely manner and operate within a standard-of-care comparable to the U.S. healthcare system.


  • Site Management

  • Data Management

  • Site Selection

  • Regulatory Submissions

  • Clinical Monitoring

  • Protocol Development


Beta Trials Platform

  • First-in-human studies

Medical Devices

  • Pilot and Pivotal Device Studies

Phases I – III

  • We partner with our clients to bring their products in a fast and efficient manner to the market with the highest quality standards


  • Diabetes/Metabolic Syndromes
  • Infectious Diseases
  • Cardiovascular
  • Neurology
  • Respiratory
  • Oncology

The Future of Clinical Trials in Colombia

Clinical Research in Latin America

Academic Leadership and Extensive Clinical Site Network for Efficient Clinical Trials

  • Our peer-to-peer management approach guarantees high patient recruitment and retention in any clinical trial

High Speed Execution

  • We offer the quickest start-up times in each country.
  • Efficient Clinical Site Selection and Contracting.
  • Benefit from our extensive network of clinical sites and streamlined contracting process.

Operational Excellence

  • Proven record of delivering rescue studies, we consistently exceed industry performance standards.
  • Our team provides efficient query resolution to keep your trial on track.

Business Insight and Flexibility

  • We offer innovative pricing models and short lines of communication to ensure maximum flexibility and cost-effectiveness.
  • At Cohortias, we prioritize  short lines of communication to ensure efficient collaboration.
  • Swift adaptation to changes in the trial landscape to keep your study on schedule.

The Future of Clinical Trials in Colombia

We provide our services with offices in:

Colombia &

Daniela Maresca
Daniela Maresca | Country Lead Argentina
Martín Hernández-Torre | CMO
Maritza Rojas | CRA II
Pedro Alvarez | Business Development Manager
Samantha Rodriguez Cohortias
Samantha Rdz. | Start-Up Manager
The Future of Clinical Trials in Colombia

The Cohortias Team

The Future of Clinical Trials in Colombia

As the largest South American Contract research Organization, we know the Advantages and Challenges Of the Region

Let Us Guide You Through The Latin American Clinical Research Landscape

The Future of Clinical Trials in Colombia

Network & Partnerships